Comparing a new fetal monitor system to standard care
Part of Women’s health & pregnancy clinical trials.
This trial is testing a new system called Femom, which monitors your baby's heartbeat during pregnancy, to see if it works as well as the standard method. If you're at least 32 weeks pregnant with one baby, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are pregnant with one baby (not twins or more).
- You are at least 32 weeks and 0 days pregnant.
- You can read and speak English well enough to understand the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new wearable device to monitor your baby's heart activity during pregnancy. It aims to see if this device works well for both low and high-risk pregnancies to detect any heart issues early.
This study tests if women with high-risk pregnancies can safely use a remote monitor at home instead of staying in the hospital. You would use a belly patch to send your baby's heart rate and your contractions to your care team.
This study tests a new method to separate a pregnant person's heart signal from their baby's heart signal during electrocardiogram (ECG) recordings. This technology could help doctors monitor both mother and baby's heart health more accurately during pregnancy.
This trial tests a remote digital care system to monitor your pregnancy at home if you have a complication that requires regular CTG (fetal heartbeat) checks. The goal is to see if this home monitoring is safe and accessible, reducing the need for hospital visits.
This study tests a special belt (Nemo Fetal Monitoring System) that tracks your baby's heart rate while you exercise. It aims to see if the belt works well and is safe during workouts in the third trimester.
This trial lets you monitor your baby's heartbeat at home with a simple device instead of coming to the hospital each time. It's for women with certain high-risk pregnancy conditions who are 32 weeks or more along.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.